The College’s Advocacy Council recently attended a call convened by the American Medical Association (AMA) with the physician community on compounding issues. AMA staff reported on a recent meeting with Food and Drug Administration (FDA) leadership on the FDA Guidance on Insanitary Conditions. Dr. Janet Woodcock, Director of the FDA’s Center for Drug Evaluation and Research, stated the FDA does not intend to regulate physician offices unless there is evidence of egregious activity and that its current guidance, which states that physician office compounding for administration to patients is not within the scope of the FDA’s regulatory initiative, will remain in place. This allays concerns that the compounding pharmacy organizations were attempting to push the FDA in a different direction.
Regarding USP, the Dec. 1 effective date for the new Chapter 797 rules has been delayed while USP deals with appeals from compounding pharmacy organizations who have raised concerns about beyond-use-dates and other technical issues. It does not appear that those issues would impact the allergy provisions in the new USP standards. USP does not have a new effective date at this time. There is some concern that the postponement could create problems at the state level, where states have incorporated the new USP 797 rules into their regulations. The Advocacy Council will continue to keep you updated on this issue. The Advocacy Council – we have you covered.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.